Someone here estimated about $30,000 per device..and if you look at recent first sell in Spain announcement (March 2022 C4) the income from customer is 55k which roughly translate to 35k euro..IMO.
now here is an article from figures written in 2020 where they assumed device cost to be $25,000 USD. Obviously article is outdated, doesn't considered inflation we going through and may not have relevant figures... But give some info...I have not read or verified information within article to be true or false .. just giving link for information.. !
https://finfeed.com/small-caps/biotech/oncosil-verge-ce-mark-approval/amp/
obviously it could be more or significantly less for each country in my opinion... !
it is a question they probably won't answer in AGM due to commercial agreement with various government... So we need to ask company to disclose number of devices sold each quarter....to help work out average....IMO.
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK, page-39
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.867K | 573.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4186862 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 15328756 | 23 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |